FOXNews.com: FDA approves prostate cancer drug

FOXNews.com FOX News Network - We Report. You Decide. // via fulltextrssfeed.com

FDA approves prostate cancer drug Aug 31st 2012, 18:03 Published August 31, 2012 Reuters A prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for treating men whose cancer has stopped responding to hormone therapy and chemotherapy, the agency said on Friday. The approval of the drug, to be sold under the brand name Xtandi, comes three months ahead of the agency's late-November decision deadline. Xtandi, or enzalutamide, is one of a new class of drugs known as androgen inhibitors, designed to interfere with the ability of testosterone to bind to prostate cancer cells.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions